- The Washington Times - Monday, August 29, 2022

A Wall Street Journal headline went this way: “Latest Covid Boosters Are Set to Roll Out Before Human Testing Is Completed.”

And with that goes the last of the U.S. Food and Drug Administration’s ethics.

The FDA doesn’t even bother to hide its embrace of Big Pharma will any longer, does it?

“The Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy and security of human and veterinary drugs, biological products, and medical devices,” the FDA’s own mission statement reads.

That must be so yesterday.

Nowadays, the FDA is in the business of pushing through products — shots, pills, supposed vaccines that aren’t so much vaccines as more shots — that come right off the pharmaceutical companies’ production lines.

“The [FDA] is expected to authorize new Covid-19 booster shots this week,” WSJ wrote, “without a staple of its normal decision-making process: data from a study showing whether the shots were safe and worked in humans.”

Why bother?

Why wait for studies showing safety and efficacy when there are so many profits that can be made? After all, Americans have already been conditioned under two-plus years of the coronavirus to fear, fear, fear and in that fear, take shots and boosters and more shots and boosters that shared this one common feature: they were billed — by the manufacturers, no less — as being 85%, 90%, 95%, 97% effective, not to mention safe. Then lo and behold, wait a bit and here’s the other shared common feature that emerged: They weren’t.

“COVID Vaccines’ Protection Dropped Sharply Over 6 Months,” WebMd.com wrote in November of 2021.

“Pfizer Covid-19 vaccine effectiveness fell quickly for kids,” CNN wrote in February.

And for more specifics, read this: “As the Delta variant became the dominant strain of the coronavirus … all three COVID-19 vaccines available to Americans lost some of their protective power, with vaccine efficacy among a large group of veterans dropping between 35% and 85%,” The Los Angeles Times wrote, also in November of 2021.

Moderna’s fell from 89% effectiveness to 58%.

Pfizer and BioNTech’s, touted around 87% effective, fell to 45%.

Johnson & Johnson’s dropped from 86% effective to 13%.

Faster than a speeding bullet — that’s how fast these shots’ efficacies fell, and fall, and continue to fall.

So what’s a Big Government committed to selling off Big Pharma’s supplies of COVID-19-tied shots to do?

Call for more shots.

Call for more boosters.

Call on Americans of all fear-filled walks of life to get their shots, get their boosters, get their kids boosted and boosted again — because the variants are coming, dontcha know. And nothing says “I care for my neighbor” like jabbing some chemicals into your arm — and into the arms of your children as young as six months old, as well.

“Th[ese] shots, modified to target the latest versions of the Omicron variant, won’t have finished testing in humans when the FDA makes its decisions,” The Journal wrote. “Instead, the agency plans to assess the shots using data from other sources such as research in mice, the profiles of the original vaccines and the performance of earlier iterations of boosters targeting older forms of Omicron.”

Yes. If it works in mice, it’ll work in humans — so goes today’s indifferent and compromised medical bureaucrats, it seems.

Here’s a clue to what’s going on — a headline from Science from July of 2018: “Hidden conflicts? Pharma payments to FDA advisers after drug approvals spark ethical concerns.”


“Why is the FDA Funded in Part by the Companies It Regulates?” UConn Today wrote in May 2021. “Nearly half the agency’s budget now comes from ‘user’ fees’ paid by companies seeking approval for medical devices or drugs.”

Follow the money.

It’s a Toucan Sam truth.

It always knows.

Because if the FDA were following the truth and government medical bureaucrats were following the science, Big Pharma’s COVID-19 gold rush, estimated in the billions and billions of dollars, would come to a quick halt.

That the FDA doesn’t even pretend anymore to put the people before Big Pharma profits only shows how emboldened and corrupt the agency has become. Perhaps a disbanding is in order. After all, it’s a sad day for America when the bureaucrats tasked with protecting our health are barely an ethical step above drug dealers in the streets.

• Cheryl Chumley can be reached at cchumley@washingtontimes.com or on Twitter, @ckchumley. Listen to her podcast “Bold and Blunt” by clicking HERE. And never miss her column; subscribe to her newsletter and podcast by clicking HERE. Her latest book, “Lockdown: The Socialist Plan To Take Away Your Freedom,” is available by clicking HERE  or clicking HERE or CLICKING HERE.

For more information, visit The Washington Times COVID-19 resource page.

Copyright © 2023 The Washington Times, LLC. Click here for reprint permission.

Please read our comment policy before commenting.

Click to Read More and View Comments

Click to Hide